Some asthma inhalers 'could stunt growth' in children, study finds
Corticosteroids, commonly found in brown inhalers, could stunt growth in children under two
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Children under two who use certain asthma medicine could be stunted in later life, a preliminary report suggests.
Doctor Antti Saari, from the University of Eastern Finland, said his team analysed data from 12,000 children to find those who used inhaled corticosteroids long-term showed signs of stunted growth, the BBC reports.
The researchers looked at information on the height of the children's parents and data on the hcildren's weight and asthma medicine in order to calculate expected height and growth.
They found an association which, if permanent, could lead to around 3cm of decreased adult height.
Experts said they would likely still be affected in adulthood, The Mirror reports.
"It is important that doctors think twice whether these steroids are needed or not in this age group," Doctor Saari said.
Corticosteroids are found in brown inhalers and are used to manage the "wheezing" symptoms of asthma.
Doctor Samantha Walker, from Asthma UK, said: “The study confirms other research suggesting ICS used in infancy can interfere with bone growth, although the impact is relatively minor.
“No parent should therefore stop their children taking these lifesaving medicines, because a slight reduction in growth is a small price to pay for medicines which may save your child’s life.”
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments